Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
ENTITY
UCB SA (UCB BB)
Watchlist
22
Analysis
Health Care
•
Belgium
UCB SA is a biopharmaceutical company. The Company specializes in the treatment of central nervous system disorders and inflammatory diseases. UCB operates worldwide.
more
Watchlist
All
Insights
Primers
New
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
SK Biopharmaceuticals
•
19 May 2020 22:44
SK Biopharm IPO Preview
SK Biopharmaceuticals (BIO SK)Â is getting ready to complete an IPO in the Korean stock market in June. The SK Biopharm will be one of the biggest...
Douglas Kim
Follow
348 Views
Share
bearish
•
Samsung Biologics
•
22 Oct 2018 22:52
Samsung BioLogics Update
Recent developments in Samsung Biologics Co., (207940 KS)'s business have been mixed with a negative skew. First, partner Merck & Co Inc (MRK...
Kemp Dolliver, CFA
660 Views
Share
bullish
•
Thematic (Sector/Industry)
•
30 Jan 2017 13:50
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...
Dion Stéfan Büchner M.D., FCAP
594 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 Dec 2016 11:44
American Society of Hematology- (ASH) Annual Conference (2016) Review
We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment...
Dion Stéfan Büchner M.D., FCAP
461 Views
Share
bullish
•
Thematic (Sector/Industry)
•
03 Dec 2016 18:43
American Society of Hematology (ASH) -Annual Conference (2016) Preview
With a focus on novel mechanisms of action (MoA), we highlight select non-Hodgkin's lymphoma (NHL) and Multiple Myeloma (MM) related abstracts at...
Dion Stéfan Büchner M.D., FCAP
363 Views
Share
First
Previous
1
2
3
4
5
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7
x